企業プロフィール
Vertex Pharmaceuticals Incorporated 株価・ニュース・カタリスト
- ティッカー:
- VRTX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
515.55 USD (+1.94%)
終値
最終更新: 2026年8月17日
108B USD
時価総額
株価変動の要因
As of Aug 17, 2026, VRTX closed up 1.94% at $515.55. No new same-company headline was identified in the current news window.
企業概要
事業概要
Vertex Pharmaceuticals is a global biotechnology company best known for its leadership in cystic fibrosis. The company has expanded beyond CF into gene editing, pain, and other high-value disease areas, making it one of the most important growth stories in biotech.
所在地とセクター分類
Vertex is headquartered in the United States and listed on NASDAQ. It has a global commercial footprint and a premium biotech profile.
ビジネスモデルの特徴
The company generates value from blockbuster product sales, disciplined R&D reinvestment, and a pipeline that extends beyond its core franchise. Investors watch CF execution, pipeline expansion, and whether new programs can preserve growth duration.
バイオ業界での位置付け
Vertex occupies the top tier of biotechnology because it combines commercial strength with innovation depth. It is less binary than a development-stage stock, but its pipeline still matters a great deal.
今後のカタリスト
- Vertex's catalysts are ALYFTREK label expansion across the CF franchise and suzetrigine's pain filings and Phase 3 progression. The market will care about whether CF can keep compounding while the pain program turns into a second growth engine, because that is what keeps the long-duration story intact.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。